Literature DB >> 33364816

Subtrochanteric Femoral Fracture in a Patient with Osteopetrosis: Treated with Internal Fixation and Complicated by Intraoperative Femoral Neck Fracture.

Xing Hua1, Zhenyu Liu2, Xinjia Wang3.   

Abstract

OBJECTIVE: Osteopetrosis (OP) is a rare, heritable skeletal disorder that is caused by osteoclast dysfunction, leading to failure of bone resorption and increased bone density. The fragility of such dense bone may result in an increased incidence of fractures. Furthermore, surgery in patients with OP is associated with increased technical difficulty and a higher risk of complications. CASE REPORT: We report a case of a 20-year-old woman with autosomal dominant OP who developed a subtrochanteric femoral fracture. The fracture was treated by open reduction and internal fixation using a dynamic hip screw. Although technical difficulties were experienced and an intraoperative femoral neck fracture occurred, the surgical outcome was satisfactory. Union of the fractures was visible on radiographs obtained 12 months postoperatively. At 2 years postoperatively, the patient was completely free of any complications resulting from her injury and treatment.
CONCLUSION: Open reduction and internal fixation may be an effective option for fractures in patients with OP. Orthopedic surgeons should be aware that the increased density and stiffness of osteopetrotic bone increases the risks of intraoperative technical difficulties, iatrogenic fractures, and postoperative complications.
© 2020 Hua et al.

Entities:  

Keywords:  autosomal dominant osteopetrosis; dynamic hip screw; osteopetrosis; subtrochanteric fracture

Year:  2020        PMID: 33364816      PMCID: PMC7751704          DOI: 10.2147/IJGM.S289265

Source DB:  PubMed          Journal:  Int J Gen Med        ISSN: 1178-7074


Introduction

Osteopetrosis (OP) is a rare, heritable skeletal disorder that was first described in 1904.1 OP is caused by osteoclast dysfunction that leads to failure of bone resorption and increased bone density2 and is characterized by hard but brittle bone with a narrow or even absent medullary canal.3 Based on the severity and pattern of inheritance, OP is divided into three types: autosomal dominant OP (ADO), autosomal recessive OP (ARO), and intermediate autosomal OP (IAO).4 The features of the three types of OP are summarized in Table 1.
Table 1

Characteristics of Three Types of OP

TypeADOAROIAO
SeverityBenignMalignantIntermediate
InheritanceAutosomal dominantAutosomal recessiveAutosomal recessive
Prevalence1/20,0001/250,000Extremely rare
DiagnosisIncidentallyEarly infancy
Main ComplaintsIncreased risk of fractures, infection, cranial nerve defectsBleeding disorder and/or sepsisIncreased risk of fractures, infection
Characteristics of Three Types of OP The fragility of such dense bone in OP may result in an increased incidence of fractures.5 Most fractures in patients with OP are treated using conservative methods, including skeletal traction and plaster fixation, due to the high risks of infection and nonunion.6 Technical challenges and complications may occur during surgery because of the hard but brittle bone structure. We report a patient with an osteopetrotic subtrochanteric fracture treated by open reduction and internal fixation with a dynamic hip screw (DHS).

Case Report

A 20-year-old woman fell while playing volleyball and incurred a subtrochanteric fracture of her right femur (Figure 1). The patient had the following typical imaging manifestations of OP: increased radiation density of the entire skeleton, absence of medullary canals, appearance of a “thick Jersey spine” or “sandwich vertebrae” caused by thickening of the vertebral endplates, and several sclerotic concentric bands (bone-within-bone) in the iliac wing (Figure 2A). Radiographs of the right knee showed no “Erlenmeyer flask” deformity of the distal femur (Figure 2B). She had no cranial and facial distortions or syndactylies of the fingers and toes, but she was short (145 cm). Laboratory examination results showed normal hematological parameters, thyroid hormone levels, and alkaline phosphatase concentration. There was no evidence of skeletal deformities, hepatosplenomegaly, or cranial nerve disturbances. The patient had no previous history of fractures, anemia, recurrent infections, or bone pain. The patient was diagnosed with ADO type II (known as Albert-Schonberg disease or marble bone disease). The X-ray examination results of her parents were normal, and they had no history of fractures. The family history of previous generations was unknown. The patient and her parents refused to undergo genetic examinations.
Figure 1

X-ray examination results of the pelvis showed a right subtrochanteric femoral fracture and osteosclerosis of the pelvis with bone-within-bone appearance in the iliac wing and obliteration of the femoral medullary canal.

Figure 2

Anteroposterior radiograph of the lumbar spine (A) showed the appearance of a “rugger jersey spine ”caused by thickening of vertebral endplates. Anteroposterior radiograph of right knee (B) showed no “Erlenmeyer flask” deformity of the distal femur.

X-ray examination results of the pelvis showed a right subtrochanteric femoral fracture and osteosclerosis of the pelvis with bone-within-bone appearance in the iliac wing and obliteration of the femoral medullary canal. Anteroposterior radiograph of the lumbar spine (A) showed the appearance of a “rugger jersey spine ”caused by thickening of vertebral endplates. Anteroposterior radiograph of right knee (B) showed no “Erlenmeyer flask” deformity of the distal femur. As access to the intramedullary canal may not have been possible in this patient, we chose to use a DHS instead of intramedullary nailing. The procedure was technically challenging. The patient was placed in the supine position on a fracture traction table under general anesthesia. The fracture was reduced under fluoroscopic visualization. New sharp drill bits were used, as blunt drill bits were more likely to break. Saline was continuously applied to help keep the drill bit cool to prevent bone necrosis and drill bit breakage. It took 30 minutes to create the hole and insert a guidewire for the lag screw. Reaming along the guidewire was also difficult and time-consuming. The sclerotic bone produced excessive resistance to tapping. During the tapping process, the surgeon felt a sudden cracking sensation through the handle. A femoral neck fracture was detected by fluoroscopy. The nondisplaced fracture was located in the middle of the femoral neck, and the lag screw provided adequate stable fixation and compression. Therefore, we decided to proceed with the original surgery plan. Subsequently, the lag and plate were attached (Figure 3A and B). During the surgery, a cortical screw and six drill bits were broken, and a few guidewires were bent.
Figure 3

Postoperative radiographs of the pelvis (A, B) showed the right subtrochanteric femoral fracture with a dynamic hip screw and fracture of the right femoral neck.

Postoperative radiographs of the pelvis (A, B) showed the right subtrochanteric femoral fracture with a dynamic hip screw and fracture of the right femoral neck. The patient was instructed to carry out active hip and knee joint training from the first postoperative day and used crutches to walk without placing weight on the affected limb for 7 days postoperatively. The patient had obtained 90° active hip flexion at 3 weeks postoperatively. She was discharged on crutches and instructed not to bear weight on the affected limb until the fracture had healed. Routine postoperative clinical and radiological follow-up examinations were performed. At 12 months postoperatively, there was complete healing of the fractures on X-ray examination, and the patient was allowed to commence full weightbearing (Figure 4A and B). At 2 years postoperatively, the patient was pain-free with full range of motion of the hip and had returned to work.
Figure 4

The X-ray examination results (A, B) showed complete healing of the subtrochanteric fracture and femoral neck fracture 2 years after surgery.

The X-ray examination results (A, B) showed complete healing of the subtrochanteric fracture and femoral neck fracture 2 years after surgery.

Discussion

OP is a rare congenital bone disorder that makes the bones abnormally dense and prone to fractures, as defective osteoclast function and failure of proper reabsorption results in sclerotic bones.7 OP is categorized clinically into three primary types: ADO, ARO, and IAO. All types of OP are usually diagnosed based on radiographic features found in a skeletal survey.8 ADO is the most common type of OP and used to be subdivided into type I and type II.9 Type I is no longer used in the classification of OP,3 while type II, which is also called Albert-Schonberg disease or marble bone disease, is identified by the classic vertebral endplate sclerosis (“sandwich” vertebrae appearance) and basal skull involvement.10 ADO type II is the most common form of OP seen in adulthood, with an incidence of 1 in 20,000.11 Patients with ADO type II generally have a normal life expectancy but experience a multitude of orthopedic complications, including mandibular osteomyelitis, fractures, hip osteoarthritis, and facial nerve palsy.5 In addition, ADO type II tends to skip a generation.12 The genetic penetrance of ADO is estimated to be 75%.13 The parents of patients with OP should be carefully evaluated and may be unaffected due to gonadal mosaicism.14 In our case, the X-ray examination results of the patient’s parents were negative. However, the patient and her parents refused to undergo genetic examinations. Genetic mutations are believed to be the cause of OP.15 Mutations in T cell immune regulator 1 (TCIRG1), chloride channel 7 (CLCN7), osteopetrosis-associated transmembrane protein 1, sorting nexin 10, and pleckstrin homology and RUN domain containing M1 lead to osteoclast-rich ARO, in which the osteoclasts are abundant but have severely impaired resorptive function.16 More than 50% of ARO cases are caused by mutations in the TCIRG1 gene.11 TCIRG1-mutated osteoclasts have a defective ruffled border and significantly reduced resorptive activity.17 Mutations in the CLCN7 gene are associated with ARO and ADO type II.18 CLCN7 is essential for bone remodeling, and mutations of the CLCN7 gene make the bone brittle.16 Mutations in TNFSF11 (also known as RANKL) and its receptor TNFRSF11A (also known as RANK) lead to osteoclast-poor ARO.19 IAO is attributed to hypomorphic mutations in the NF-κB essential regulator gene.11,20 The development of genetic technology has led to the discovery of new genes associated with OP, and the genetics of OP warrants further study. Due to the high density and brittleness of the bones in OP, surgical interventions lead to a high incidence of complications; therefore, most fractures in patients with OP are treated conservatively. However, surgical treatment may be a better choice for patients in pursuit of an active life. Intramedullary nailing is effective for subtrochanteric fractures in patients without OP. However, patients with OP have a narrow or even completely absent medullary canal, which makes surgery challenging. Various osteosynthesis techniques and implants have been reported, each with its own advantages and disadvantages. Table 2 summarizes the published cases describing the surgical treatment of subtrochanteric femoral fractures in patients with OP between 2010 and 2020. In our case, internal fixation with a DHS obtained a satisfactory surgical outcome.
Table 2

Summary of the Published Cases Describing the Surgical Treatment of Subtrochanteric Femoral Fractures in Patients with OP (2010–2020)

ArticleAgeGenderFracture LocalizationImplantComplicationFollow-Up Period
Golden et al(2010)2127MBilateral subtrochantericDCSDelayed union3 years
Amit et al(2010)2235FRight subtrochantericLCPContralateral stress fracture23 weeks
38FLeft subtrochantericLCPNone21 weeks
Sonohata et al(2011)2361FRight subtrochantericHADelayed union2 years
Kumar et al (2012)2445MBilateral subtrochantericDHSDelayed union11 months
Kumbaraci et al(2013)2521FBilateral subtrochantericIMNDelayed union12 months
Sen et al (2013)26Mean 264 M/1 F4 subtrochanteric(1 bilateral)LCPNone3 months
Aslan et al (2014)2724FBilateral subtrochantericPlate-screwNone12 months
Seyfettinoglu et al (2016)2849FLeft subtrochantericIMNInfection12 months
Huang et al (2017)2967MLeft subtrochantericLCPDelayed union12 months
Matsuo et al (2018)3027MRight subtrochantericLCPNon-union32 months
Hasan et al (2018)3123MRight subtrochantericLCPNone7 months
Chawla et al (2019)3239MRight subtrochantericDCSNone12 months
40MLeft subtrochantericDCSDelayed union12 months
35MLeft subtrochantericLCPNon-union and peri-implant stress fracture4 years
Hiyama et al (2020)3338MLeft subtrochantericLCPDelayed union7 years
79FLeft subtrochantericLCPDelayed union8 years
Kim et al (2020)3426MLeft subtrochantericIMNDelayed union30 months
70FBilateral subtrochantericIMN(left) and LCP(right)Delayed union20 months

Abbreviations: M, male; F, female; DCS, dynamic condylar screw; LCP, locking compression plate; HA, hemiarthroplasty; DHS, dynamic hip screw; IMN, intramedullary nail.

Summary of the Published Cases Describing the Surgical Treatment of Subtrochanteric Femoral Fractures in Patients with OP (2010–2020) Abbreviations: M, male; F, female; DCS, dynamic condylar screw; LCP, locking compression plate; HA, hemiarthroplasty; DHS, dynamic hip screw; IMN, intramedullary nail. Patients with OP have a poor bone blood supply and relative osteopenia, which are associated with increased risks of infection and osteomyelitis.35 An infection rate of 12% was reported in a case series of patients with OP.36 Furthermore, the increased density and stiffness of osteopetrotic bone makes it susceptible to drill bit breakages and iatrogenic fractures, as in our case. Therefore, it is crucial to have a detailed presurgical plan when treating fractures in patients with OP. Surgeons should be aware that an increased number of drills, batteries, and some other osteosynthesis implants must be obtained for the surgery. The processes of drilling, reaming, and implantation into dense brittle bone are challenging and exhausting, and extra care and caution are required. In our case, the fracture was located in the middle of the femoral neck, and the lag screw was able to apply enough stable fixation and compression. Another problem encountered when treating fractures in patients with OP is delayed union or nonunion. Histologically, the bone callus that develops after fracture in patients with OP is apparently normal in the early stages, but there is no Haversian organization in the mature callus.37 Fractures take more time to heal in patients with OP than in the general population. The mean time to fracture union in one study of nine patients with OP was 8.3 months (7 to 12).38 In our case, the fracture was healed at 12 months postoperatively and there was no sign of infection.

Conclusion

Open reduction and internal fixation may be an effective option for treating fractures in patients with OP. Orthopedic surgeons should be aware that the increased density and stiffness of osteopetrotic bone increases the risks of intraoperative technical difficulties, iatrogenic fractures, and postoperative complications.
  38 in total

Review 1.  Orthopedic management of osteopetrosis: results of a survey and review of the literature.

Authors:  D G Armstrong; J T Newfield; R Gillespie
Journal:  J Pediatr Orthop       Date:  1999 Jan-Feb       Impact factor: 2.324

Review 2.  Treatment of bilateral simultaneous subtrochanteric femur fractures with proximal femoral nail antirotation (PFNA) in a patient with osteopetrosis: case report and review of the literature.

Authors:  Mert Kumbaraci; Levent Karapinar; Mustafa Incesu; Ahmet Kaya
Journal:  J Orthop Sci       Date:  2012-08-07       Impact factor: 1.601

3.  Traumatic multiple cervical spine injuries in a patient with osteopetrosis and its management.

Authors:  Ashok Keshav Rathod; Rakesh Padmakar Dhake; Mandar Deepak Borde
Journal:  Eur Spine J       Date:  2017-04-09       Impact factor: 3.134

Review 4.  Infantile malignant, autosomal recessive osteopetrosis: the rich and the poor.

Authors:  Anna Villa; Matteo M Guerrini; Barbara Cassani; Alessandra Pangrazio; Cristina Sobacchi
Journal:  Calcif Tissue Int       Date:  2008-12-12       Impact factor: 4.333

5.  Simple reproducible technique in treatment for osteopetrotic fractures.

Authors:  Ramesh K Sen; Nirmal Raj Gopinathan; Rajesh Kumar; Uttam Chand Saini
Journal:  Musculoskelet Surg       Date:  2012-09-16

Review 6.  Case reports: treatment of subtrochanteric and ipsilateral femoral neck fractures in an adult with osteopetrosis.

Authors:  Patrick Birmingham; Kathleen A McHale
Journal:  Clin Orthop Relat Res       Date:  2008-04-23       Impact factor: 4.176

7.  Open reduction and internal fixation using a locking compression plate as treatment for subtrochanteric fracture in two patients with osteopetrosis.

Authors:  Shuhei Hiyama; Tsuneari Takahashi; Tomohiro Matsumura; Katsushi Takeshita
Journal:  Injury       Date:  2019-11-22       Impact factor: 2.586

8.  Fracture callus in osteopetrosis.

Authors:  L de Palma; A Tulli; G Maccauro; S P Sabetta; M del Torto
Journal:  Clin Orthop Relat Res       Date:  1994-11       Impact factor: 4.176

9.  Successful open reduction and internal fixation for displaced femoral fracture in a patient with osteopetrosis: Case report and lessons learned.

Authors:  Jiangfa Huang; Jianke Pan; Mingtao Xu; Shuchai Xu
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

10.  Radiographic imaging, densitometry and disease severity in Autosomal dominant osteopetrosis type 2.

Authors:  Lauren M Ladd; Erik A Imel; Paul J Niziolek; Ziyue Liu; Stuart J Warden; Yun Liang; Michael J Econs
Journal:  Skeletal Radiol       Date:  2020-10-03       Impact factor: 2.199

View more
  1 in total

1.  Pediatric patient with a bilateral Salter-Harris II fracture and slipped capital femoral epiphysis secondary to autosomal recessive osteopetrosis.

Authors:  Ayham Jaber; Martin Schwarze; Verena Steinle; Marco Götze; Sébastien Hagmann
Journal:  Orthopadie (Heidelb)       Date:  2022-07-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.